LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291)

Market Cap	5.50B -18.3%
Revenue (ttm)	605.14M +34.9%
Net Income	314.88M +33.0%
EPS	0.91 +33.0%
Shares Out	346.75M
PE Ratio	17.45
Forward PE	14.27
Dividend	0.67 (4.25%)
Ex-Dividend Date	May 26, 2025

Volume	2,207,000
Average Volume	735,720
Open	16.00
Previous Close	15.78
Day's Range	15.28 - 16.37
52-Week Range	13.50 - 33.00
Beta	-0.39
RSI	55.15
Earnings Date	Mar 30, 2026

About HKG:2291

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the manufacture and sale of interventional treatment series occluders for defective congenital heart disease. It operates through Occluder Business and Heart Valve Business segments. The company also research and develops heart valve medical devices. Its products include atrial septal defect, ventricular septal defect, patent ductus arteriosus, patent foramen ovale, left atrial appendage, aortic and peripheral, and aortic and mitral valve occluder ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1994
• Employees: 374
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2291

Financial Performance

In 2024, HKG:2291's revenue was 471.64 million, an increase of 44.40% compared to the previous year's 326.62 million. Earnings were 245.56 million, an increase of 62.22%.

Financial numbers in CNY